Raymond James Financial »

Silence Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $152k 25k 6.08

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)

View all positions for Raymond James Financial

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Nantahala Capital Management
Vivo Capital
Nextech Invest
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
5AM Venture Management
Polygon Management
Millennium Management
SG Americas Securities
Boothbay Fund Management
UBS Group

View all funds holding Silence Therapeutics